Evidence map›Paper›PMID 42358699›Full record

ArticleJACS Au2026

A Metal-Organic Framework Platform Enabling Visible-to-Ultraviolet Upconversion-Driven Heterogeneous Photochemistry.

Subhrajyoti Ghosh, Sakura Nakagawa, Masanori Uji, Manpreet Singh, Naoto Matsumoto, Miku Inoue, Bhavesh Parmar, Nobuhiro Yanai

Abstract read
In one paragraph

Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Subhrajyoti GhoshDepartment of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.
Sakura NakagawaDepartment of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.
Masanori UjiDepartment of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.ORCID https://orcid.org/0009-0001-6521-9236
Manpreet SinghDepartment of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.ORCID https://orcid.org/0000-0002-0335-6147
Naoto MatsumotoDepartment of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.ORCID https://orcid.org/0009-0002-7929-8868
Miku InoueDepartment of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.
Bhavesh ParmarDepartment of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.ORCID https://orcid.org/0000-0003-4263-7635
Nobuhiro YanaiDepartment of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.ORCID https://orcid.org/0000-0003-0297-6544

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triplet-triplet annihilation photon upconversion (TTA-UC) provides an attractive strategy for converting low-energy photons into higher-energy photons under low excitation intensities, enabling diverse applications in photocatalysis, optoelectronics, and solar energy conversion. However, realizing efficient and durable visible-to-ultraviolet (vis-to-UV) TTA-UC in the solid materials remains a major challenge, primarily due to nonemissive annihilator aggregation, phase separation between sensitizers and annihilators, and poor photostability. Herein, we report, for the first time, vis-to-UV TTA-UC realized within a metal-organic framework (MOF) and demonstrate its utility in a heterogeneous photochemical reaction. A hybrid upconversion system is constructed by co-incorporating a

Indexed as

Metal−Organic FrameworkPhotocatalysisPhoton UpconversionPhotostabilityUltraviolet LightUncaging Reaction

Identifiers

PMID42358699
PMCPMC13291878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.